Vivien C Hollmann, Alastair R J Darwood, Pawandeep S Sarai, Paul H Strutton, William Harrop-Griffiths, Christopher J Mullington
{"title":"Psychomotor Responses to Independent Visual, Auditory and Tactile Electrical stimuli during Sevoflurane sedation (PRIVATES).","authors":"Vivien C Hollmann, Alastair R J Darwood, Pawandeep S Sarai, Paul H Strutton, William Harrop-Griffiths, Christopher J Mullington","doi":"10.1016/j.bja.2025.01.034","DOIUrl":"https://doi.org/10.1016/j.bja.2025.01.034","url":null,"abstract":"<p><strong>Background: </strong>Patient-controlled sedation has potential benefits, including rapid recovery and improved patient satisfaction. During patient-controlled sedation, the recipient presses a button to self-administer the sedative. The safety and efficacy of this method is dependent upon the dose relationships between the sedative's desired effects, its impact on the ability to press a button, and adverse effect occurrence. This study aimed to investigate the relationship between sedation, psychomotor function, and adverse effect occurrence during clinician-controlled sevoflurane sedation.</p><p><strong>Methods: </strong>15 healthy participants (10 males) were administered a sevoflurane dose-escalation protocol starting at 0 kPa and increasing in 0.2 kPa increments until a protocol endpoint occurred. Sevoflurane was delivered using conventional anaesthetic apparatus. At each sevoflurane dose, Richmond Agitation-Sedation Scale (RASS) and psychomotor function were assessed. Protocol endpoints included airway, respiratory, or cardiovascular compromise; agitation (RASS ≥+2); and sedation >3 h.</p><p><strong>Results: </strong>The protocol endpoint was sedation >3 h for nine (60%) participants, agitation for five (33%) participants, and tonic movements for one (7%) participant. The median [range] sevoflurane dose was 0.4 [0.2-1.0] kPa when RASS <0 (sedation dose), 1.2 [0.6-2.0] kPa when participants were unable to complete reaction time testing (button-press dose), and 1.6 [1.2-2.2] kPa at the protocol endpoint (endpoint dose). The sedation dose was less than the button-press dose (P<0.0001), and the button-press dose was less than the endpoint dose (P=0.002).</p><p><strong>Conclusions: </strong>Patient-controlled sevoflurane sedation is potentially feasible in a healthy population within the dose range 0.4-1.2 kPa. Concurrent reaction time monitoring could minimise the risk of agitation.</p>","PeriodicalId":9250,"journal":{"name":"British journal of anaesthesia","volume":" ","pages":""},"PeriodicalIF":9.1,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143669100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mark Brown, Fayez Elsawy, Benjamin Allison, Brendan McGrath
{"title":"Dual antiplatelet therapy and tracheostomy practice in the intensive care unit. Comment on Br J Anaesth 2025; 134: 571-3.","authors":"Mark Brown, Fayez Elsawy, Benjamin Allison, Brendan McGrath","doi":"10.1016/j.bja.2025.02.020","DOIUrl":"https://doi.org/10.1016/j.bja.2025.02.020","url":null,"abstract":"","PeriodicalId":9250,"journal":{"name":"British journal of anaesthesia","volume":" ","pages":""},"PeriodicalIF":9.1,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143669071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Forbes McGain, Emily Balmaks, Eugenie Kayak, Cas Woinarski, Anthony Hull, Stephan Williams, Jane Muret
{"title":"Evaluation of a protocol to reduce the environmental impact of anaesthetic gases. Comment on Br J Anaesth 2024; 133: 1489-91.","authors":"Forbes McGain, Emily Balmaks, Eugenie Kayak, Cas Woinarski, Anthony Hull, Stephan Williams, Jane Muret","doi":"10.1016/j.bja.2025.02.019","DOIUrl":"https://doi.org/10.1016/j.bja.2025.02.019","url":null,"abstract":"","PeriodicalId":9250,"journal":{"name":"British journal of anaesthesia","volume":" ","pages":""},"PeriodicalIF":9.1,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143669093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jack Rea, Adam Khan, Nicholas Boyne, Alison Duke, Matt Vassar
{"title":"Discrepancies in adverse event reporting for ketamine trials.","authors":"Jack Rea, Adam Khan, Nicholas Boyne, Alison Duke, Matt Vassar","doi":"10.1016/j.bja.2025.02.015","DOIUrl":"https://doi.org/10.1016/j.bja.2025.02.015","url":null,"abstract":"","PeriodicalId":9250,"journal":{"name":"British journal of anaesthesia","volume":" ","pages":""},"PeriodicalIF":9.1,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143669065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Heitor Medeiros, Sara Amaral, Rafael A Lombardi, Elizabeth Korn, Ariel Mueller, Lucas P Trevisan, Hugo W Araújo, Wallace Andrino, A Sassan Sabouri
{"title":"Effects of combined intrathecal dexmedetomidine and local anaesthetic on analgesia duration of spinal anaesthesia: a systematic review and meta-analysis of randomised controlled trials.","authors":"Heitor Medeiros, Sara Amaral, Rafael A Lombardi, Elizabeth Korn, Ariel Mueller, Lucas P Trevisan, Hugo W Araújo, Wallace Andrino, A Sassan Sabouri","doi":"10.1016/j.bja.2025.02.022","DOIUrl":"https://doi.org/10.1016/j.bja.2025.02.022","url":null,"abstract":"","PeriodicalId":9250,"journal":{"name":"British journal of anaesthesia","volume":" ","pages":""},"PeriodicalIF":9.1,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143669074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Zoe Keon-Cohen, Heather Loane, Lorena Romero, Daryl Jones, Jane Banaszak-Holl
{"title":"Advance care planning and goals of care discussions in perioperative care: a scoping review.","authors":"Zoe Keon-Cohen, Heather Loane, Lorena Romero, Daryl Jones, Jane Banaszak-Holl","doi":"10.1016/j.bja.2025.01.031","DOIUrl":"https://doi.org/10.1016/j.bja.2025.01.031","url":null,"abstract":"<p><strong>Background: </strong>Advance care planning is well established in general medical wards, but its implementation in anaesthesia and perioperative care presents unique challenges. Effective communication and shared decision-making regarding treatment limitations are essential to clarify care goals and provide timely, high-quality end-of-life care. Terminally ill patients with complex care needs can experience a higher risk of postoperative mortality during anaesthesia.</p><p><strong>Methods: </strong>This scoping review examines the literature describing when and how advance care planning has been studied in perioperative care, focusing on patient characteristics, the content of advance care planning discussions, and impact on patient outcomes. The study follows PRISMA-ScR guidelines. Articles were collected from MEDLINE, CENTRAL, and CINAHL databases, using search terms from MeSH and synonyms for anaesthesia, surgery and perioperative care, advance care planning, living wills or advance directives, goals of care and terminal care, resuscitation orders, shared decision-making, and palliative care discussions.</p><p><strong>Results: </strong>Advance care planning documentation varies across surgical specialties and settings, with higher rates in emergency and palliative surgery. Patient factors, such as age and comorbidities, impact completion of advance care planning. Structurally, the presence of interdisciplinary teams, increased decision-making aids, and structured discussions improve implementation. Barriers included a lack of consistency in terminology, poor timing of needed conversations, a lack of cultural sensitivities, and patient fears of abandonment and palliative care.</p><p><strong>Conclusions: </strong>Further research is required to determine the most appropriate and beneficial methods and outcomes for implementing advance care planning into perioperative and end-of-life care, ensuring appropriate, timely, and patient-oriented care delivery.</p>","PeriodicalId":9250,"journal":{"name":"British journal of anaesthesia","volume":" ","pages":""},"PeriodicalIF":9.1,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143669063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Use of low-glucose isotonic solutions intraoperatively in infants: reassuring data regarding the risk of intraoperative hypoglycaemia.","authors":"Per-Arne Lönnqvist","doi":"10.1016/j.bja.2025.02.013","DOIUrl":"https://doi.org/10.1016/j.bja.2025.02.013","url":null,"abstract":"<p><p>In years past, it was standard of practice to use high-glucose, low-sodium i.v. infusions as maintenance fluids intraoperatively. However, this tradition was associated with the risk of developing severe postoperative hyponatraemia, which sometimes resulted in cerebral oedema and even death. Research, information, consensus guidelines, and lobbying the pharma industry to produce a low-glucose isotonic solution that would be optimised for use in children has now resulted in a much needed change of practice. However, an outstanding issue has been whether 1% glucose in i.v. solutions is enough or too little to safeguard against intraoperative hypoglycaemia in infants. Lindestam and colleagues have now reported results from a relatively large prospective observational study (n=365) that use of a 1% glucose isotonic solution at normal maintenance rates resulted in a zero incidence of hypoglycaemia (defined as glucose <3 mM) with maintained sodium homeostasis. A major issue in the context of intraoperative maintenance fluids in children has now been answered.</p>","PeriodicalId":9250,"journal":{"name":"British journal of anaesthesia","volume":" ","pages":""},"PeriodicalIF":9.1,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143669103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Etomidate and its derivatives: time to say goodbye? You say goodbye and I say hello. Response to Br J Anaesth 2025; 134: 11-3.","authors":"Yvonne Nyman, Per-Arne Lönnqvist","doi":"10.1016/j.bja.2025.02.016","DOIUrl":"https://doi.org/10.1016/j.bja.2025.02.016","url":null,"abstract":"","PeriodicalId":9250,"journal":{"name":"British journal of anaesthesia","volume":" ","pages":""},"PeriodicalIF":9.1,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143669077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yu-Hang Cai, Le-Qi Dong, John W Zhong, Zheng Lin, Cong-De Chen, Li-Bin Zhu, Xiao-Kun Lin, Peter Szmuk, Hua-Cheng Liu
{"title":"ED50 and ED95 of remimazolam for loss of consciousness in young children.","authors":"Yu-Hang Cai, Le-Qi Dong, John W Zhong, Zheng Lin, Cong-De Chen, Li-Bin Zhu, Xiao-Kun Lin, Peter Szmuk, Hua-Cheng Liu","doi":"10.1016/j.bja.2025.02.004","DOIUrl":"https://doi.org/10.1016/j.bja.2025.02.004","url":null,"abstract":"<p><strong>Background: </strong>The optimal single i.v. bolus dose of remimazolam for induction of general anaesthesia in children is not defined. We aimed to determine the 50% (ED50) and 95% (ED95) effective doses of remimazolam for inducing loss of consciousness in children.</p><p><strong>Methods: </strong>A total of 120 children, aged 1-12 yr, were divided into three groups, with 40 children in each group: toddler (1 to <3 yr), preschool (≥3 to <6 yr), and school-age group (≥6 to <12 yr). Each child received a single i.v. bolus of remimazolam, with doses determined using a biased coin design up-and-down method. The primary outcome was the ED50 and ED95 of remimazolam for inducing loss of consciousness. Secondary outcomes included the incidence of hypotension, respiratory depression, and adverse events.</p><p><strong>Results: </strong>The ED50 and ED95 of remimazolam were 0.42 mg kg<sup>-1</sup> (95% confidence interval [CI] 0.37-0.44) and 0.57 mg kg<sup>-1</sup> (95% CI 0.48-0.59), respectively, in the toddler group; 0.41 mg kg<sup>-1</sup> (95% CI 0.35-0.47) and 0.57 mg kg<sup>-1</sup> (95% CI 0.50-0.59), respectively, in the preschool group; and 0.30 mg kg<sup>-1</sup> (95% CI 0.28-0.34) and 0.43 mg kg<sup>-1</sup> (95% CI 0.37-0.44), respectively, in the school-age group. No significant cases of hypotension, respiratory depression, bradycardia, or other adverse events occurred in any of the three groups.</p><p><strong>Conclusions: </strong>A single i.v. bolus of remimazolam at estimated doses of 0.45-0.60 mg kg<sup>-1</sup> for children aged 1-6 yr and 0.35-0.45 mg kg<sup>-1</sup> for those aged 6-12 yr effectively induces loss of consciousness in children.</p><p><strong>Clinical trial registration: </strong>ClinicalTrials.gov (NCT06061159).</p>","PeriodicalId":9250,"journal":{"name":"British journal of anaesthesia","volume":" ","pages":""},"PeriodicalIF":9.1,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143662602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}